Drug-resistant bacteria has become a pressing public health problem, exacting a rising human and financial toll. GlaxoSmithKline announced that it has found a compound that could help attack such 'superbugs'.
GlaxoSmithKline diabetes drug Avandia has been found to have increased heart attack risk compared to similar medication. But a majority of the Food and Drug Administration's panel of outside experts have voted to keep the drug on the market -- though new restrictions are likely.







